AC Immune SA Made Headway
Tue, Jun 27, 2023 at 07:53 PM
AC Immune SA (ACIU:NASDAQ) shot up at $3.4, a gain of 71.7%. On Tue, Jun 27, 2023, ACIU:NASDAQ touched a New 2-Week High of $3.4. The stock appeared on our News Catalysts scanner on Tue, Jun 27, 2023 at 07:29 AM in the 'BIOTECH' category. From Tue, Jun 13, 2023, the stock recorded 44.44% Up Days and 40.00% Green Days
About AC Immune SA (ACIU:NASDAQ)
AC Immune SA is a clinical stage biopharmaceutical company. It discovers, designs and develops novel, proprietary medicines for treatment of neurodegenerative diseases with the help of proprietary platforms.
Top 10 Gainers:
- Black Diamond Therapeutics, Inc. (BDTX:NASDAQ), 235.87%
- AC Immune SA (ACIU:NASDAQ), 71.72%
- Leafly Holdings Inc. (LFLY:NASDAQ), 54.81%
- Centogene N.V. (CNTG:NASDAQ), 50.82%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 38.96%
- Ryvyl Inc Com (New) (RVYL:NASDAQ), 36.29%
- CalciMedica Inc Com (New) (CALC:NASDAQ), 33.13%
- VivoPower International PLC (VVPR:NASDAQ), 32.35%
- Statera Biopharma Inc. (STAB:NASDAQ), 25.46%
- Enovix Corporation (ENVX:NASDAQ), 25.23%